Announcement of monthly exercise status for third-party allotted stock acquisition rights. There were 0 exercises for Series 7\u20139 in September 2026; total unexercised remaining shares amount to 2,?46,500 shares etc. Cumulative exercise ratio is up to 2.33% (Series 7).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3490","jir_company_name":"Azplanning Co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/3490-20261001-01.pdf","jir_short_summary":"Announcement of monthly exercise status for third-party allotted stock acquisition rights. There were 0 exercises for Series 7\u20139 in September 2026; total unexercised remaining shares amount to 2,?46,500 shares etc. Cumulative exercise ratio is up to 2.33% (Series 7).","jir_summary":"### Overview of Exercise Status\nThis report discloses the monthly exercise status of the 7th, 8th and 9th series stock acquisition rights allotted to third parties. During the September period, no exercises of stock acquisition rights occurred for any series, and the exercise ratio relative to the total number of issued shares is stated as 0.00%. The cumulative exercise ratio for the 7th series is 2.33%, with unexercised remaining shares of 146,500 shares (1,465 units); the 8th series has 150,000 shares, and the 9th series has 75,000 shares.\n\n### Impact on Shareholders and Outlook\nAt this time, specific uses of funds or detailed dilution impact have not been disclosed. Exercise progress remains low, and continued retention of unexercised rights may result in limited future dilution. However, exercise status is updated monthly, so attention should be paid to future disclosures.","jir_financial_highlights":"Unexercised remaining shares (shares): 146,500 shares (Month-over-month: Unknown)\nUnexercised remaining shares (shares): 150,000 shares (Month-over-month: Unknown)\nUnexercised remaining shares (shares): 75,000 shares (Month-over-month: Unknown)","jir_category":"","jir_hashtags":"#Azplanning, #StockAcquisitionRights, #StockOptionAnalysis","jir_key_figures":"Unexercised remaining shares (shares): Series 7 146,500 shares, Series 8 150,000 shares, Series 9 75,000 shares\nCumulative exercise ratio: Series 7 2.33%, Series 8 0.00%, Series 9 0.00%\nNumber of exercises in the subject month: Total 0 cases","jir_meta_title":"Azplanning Co.,Ltd. Announces Monthly Exercise Status of Third-Party Allotted Stock Acquisition Rights | September 2026","jir_meta_description":"Azplanning Co.,Ltd. disclosed the September exercise status for the 7th, 8th and 9th series of third-party allotted stock acquisition rights. No exercises occurred; summary of cumulative exercise ratios and unexercised remaining shares provided.","jir_og_title":"Azplanning Co.,Ltd. | Monthly Exercise Status of Stock Acquisition Rights Announced","jir_og_description":"Detailed disclosure of the September exercise status for third-party allotted stock acquisition rights. Zero exercises; check unexercised remaining shares and cumulative ratios.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60119,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-125631","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n